Physician profile
Leon Robinson
NPI 1871743104
$1,298.46
in general payments reported to CMS, 2019-2025
13 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $69.58 · 2021: $56.29 · 2022: $83.63 · 2023: $108 · 2024: $131 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $585.09 | 2019-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Kerecis Limited | $154.51 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Misonix INC | $110.18 | 2019 | |
| Kci USA, INC. | $96.93 | 2019 | |
| Smith+Nephew, INC. | $83.05 | 2024-2025 | Collagenase Santyl |
| Janssen Biotech, INC. | $72.43 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.67 | 2019 | |
| Abbvie INC. | $28.79 | 2023 | Dalvance |
| Napo Pharmaceuticals INC | $27.90 | 2019 | |
| Next Science LLC | $23.68 | 2023 | Surgx, Xperience, Blastx |
| Tetraphase Pharmaceuticals, INC. | $20.89 | 2019 | |
| Convatec INC. | $16.35 | 2022 | |
| Melinta Therapeutics, LLC | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.